|
|
 |
|
Viewing report
|
|
|
|
MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
Select Biosciences Ltd, July 2009, Pages: 196
This is the latest and most up-to-date market analysis report addressing microRNA diagnostics, therapeutics and cancer personalized medicine. The cancer personalized medicine marketplace provides a paradigm for the development of microRNA diagnostics and therapeutics and this market report brings together these emerging disciplines. This comprehensive report provides a thorough discussion and analysis of the cancer personalized medicine space, from both a technical as well as market-focused perspective.
Cancer personalized medicine represents the leading-edge of the broader personalized medicine marketplace and we map the qualitative and quantitative market trends and metrics in this report (including market segmentation, market sizing, growth rates, revenue projections broken-out by product areas, and market penetration of various technologies in cancer personalized medicine). Analysis of the cancer personalized medicine space through bottom-up analysis, via detailed market surveys administered to a worldwide industry participant pool, are presented in this report. Commercial and competitive landscape of the emerging microRNA diagnostics/therapeutics marketplace are presented in the context of the leading edge of this space - cancer.
This comprehensive industry report addresses the technical, commercial, and competitive landscape of microRNA diagnostics and therapeutics – an emerging space in the broader microRNA research marketplace.
This report also brings together the latest technical and market analysis of cancer personalized medicine the leading edge of the broader personalized medicine marketplace.
Extensive worldwide technical and market analyses presented in this report:
- Technical aspects of the broader personalized medicine space as well as cancer personalized medicine
- Current products in the cancer personalized medicine space - their mechanisms of action, projected revenues, competitive position and benchmarking, with emphasis on breast cancer personalized medicine
- Segmentation of the broader personalized medicine marketplace by therapeutic/disease area addressed currently
- Segmentation of the cancer personalized medicine market by types of cancer addressed currently
- Results and analyses from recent worldwide market surveys focusing upon the qualitative and quantitative trends in cancer personalized medicine.
Areas of coverage include the market penetrance of various technologies used industry-wide, distribution of the industry with respect to types of biomarkers studied, penetrance of diagnostic platforms, and drivers/challenges to market adoption
- MicroRNAs identified with association with specific diseases
- MicroRNA-based personalized medicine
- MicroRNA diagnostics/therapeutics industry trends and milestones
- MicroRNA diagnostics/therapeutics competitive landscape
Customers who bought this item also bought
Epigenetics and MicroRNA Diagnostics/Therapeutics 2008
Molecular Diagnostics - Technologies, Markets and Companies
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Molecular Diagnostics in Cancer Testing
Biomarkers - Global Strategic Business Report
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
Epigenetics: Tools, Diagnostics, Drugs and World Market
Companion Diagnostics in Personalized Medicine and Cancer Therapy
|
|
|
|
